Yep three years, perhaps we need one final capitulation like we had back in March 2020 before we begin our ascent.
If we can expect early readouts as soon as Nov, that really is not far away.
The ann. that kicked off the rerate back in 2020 was "Ann: Successful Efficacy Result on Path to First in Human Studies" for RP. It's incredible that we'll be commencing first patient dosing this month and yet are trading at the same price as back then (albeit we have incurred some dilution since then).
Lets hope a big blue volume bar on the weekly timeframe isn't far away
Valuing PYC, page-55
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
-0.005(4.17%) |
Mkt cap ! $536.5M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.5¢ | 11.5¢ | $609.0K | 5.065M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 1814616 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 922472 | 6 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |